Results of a phase 1 clinical trial reported at the American Association for Cancer Research (AACR) annual conference show that orally administered Rigosertib is well tolerated in patients with advanced solid tumors. This ...
Apr 9, 2013
0
0
Despite great advances in medicine, cancer remains a death sentence for many. "Patients are still dying from breast cancer relapse," says Jian Yuan Goh, of A*STAR's Genome Institute of Singapore. The researcher and his colleagues, ...
Mar 16, 2018
0
2
The spreading of a cancerous tumor from one part of the body to another may occur through pure chance instead of key genetic mutations, a new study has shown.
Jul 22, 2014
0
0
(Medical Xpress)—Women whose early-stage breast cancers had reduced numbers of copies of the LRIG1 gene were more likely to have a relapse or die of their disease, according to data published in Cancer Research, a journal ...
May 30, 2014
0
0
